Extended-release alfuzosin hydrochloride: A new alpha-adrenergic receptor antagonist for symptomatic benign prostatic hyperplasia

The American Journal of Geriatric Pharmacotherapy ◽

10.1016/s1543-5946(04)90003-7 ◽

2004 ◽

Vol 2 (1) ◽

pp. 14-23 ◽

Author(s):

David R.P Guay

Keyword(s):

Benign Prostatic Hyperplasia ◽

Receptor Antagonist ◽

Adrenergic Receptor ◽

Extended Release ◽

Prostatic Hyperplasia ◽

Symptomatic Benign Prostatic Hyperplasia ◽

Alpha Adrenergic Receptor ◽

Alfuzosin Hydrochloride

Download Full-text

Silodosin: A selective α1A-adrenergic receptor antagonist for the treatment of benign prostatic hyperplasia

Clinical Therapeutics ◽

10.1016/j.clinthera.2009.11.024 ◽

2009 ◽

Vol 31 (11) ◽

pp. 2489-2502 ◽

Author(s):

Sara Schilit ◽

Kenza E. Benzeroual

Keyword(s):

Benign Prostatic Hyperplasia ◽

Receptor Antagonist ◽

Adrenergic Receptor ◽

Prostatic Hyperplasia

Download Full-text

Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the α-adrenergic receptor antagonist

The Aging Male ◽

10.1080/13685538.2017.1358261 ◽

2017 ◽

Vol 20 (4) ◽

pp. 250-256 ◽

Author(s):

Xiaoqiang Qian ◽

Ding Xu ◽

Hailong Liu ◽

Xiaoling Lin ◽

Yongjiang Yu ◽

...

Keyword(s):

Benign Prostatic Hyperplasia ◽

Receptor Antagonist ◽

Genetic Variants ◽

Adrenergic Receptor ◽

Prostatic Hyperplasia

Download Full-text

Experience of Combination Therapy with Alpha Adrenergic Receptor Antagonist and Anticholinergic Agent in Patients with Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: 12 Month Follow-up

Korean Journal of Andrology ◽

10.5534/kja.2011.29.3.236 ◽

2011 ◽

Vol 29 (3) ◽

pp. 236 ◽

Author(s):

Yu Mi Seo ◽

Hyung Jee Kim

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Adrenergic Receptor ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Anticholinergic Agent ◽

Alpha Adrenergic Receptor ◽

Urinary Tract Symptoms ◽

Download Full-text

PD21-04 INFLUENCE OF NAFTOPIDIL, ALPHA 1D/A -ADRENERGIC RECEPTOR ANTAGONIST, ON PLASMA MONOAMINE LEVELS AND LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA

The Journal of Urology ◽

10.1016/j.juro.2014.02.1681 ◽

2014 ◽

Vol 191 (4S) ◽

Author(s):

Katsumi Kadekawa ◽

Saori Nishijima ◽

Katsuhiro Ashitomi ◽

Kimio Sugaya

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Receptor Antagonist ◽

Lower Urinary Tract Symptoms ◽

Adrenergic Receptor ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

Download Full-text

901 SRD5A1 and SRD5A2 genes are associated with the treatment for benign prostatic hyperplasia with the combination of 5α-reductase inhibitors and α-adrenergic-receptor antagonist

European Urology Supplements ◽

10.1016/s1569-9056(13)61380-9 ◽

2013 ◽

Vol 12 (1) ◽

pp. e901

Author(s):

X. Gu ◽

R. Na ◽

W. Li ◽

S. Tao ◽

L. Tian ◽

...

Keyword(s):

Benign Prostatic Hyperplasia ◽

Receptor Antagonist ◽

Adrenergic Receptor ◽

Prostatic Hyperplasia ◽

Reductase Inhibitors

Download Full-text

Role of the newer alpha, -adrenergic-receptor antagonistsin the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms

Clinical Therapeutics ◽

10.1016/j.clinthera.2004.11.006 ◽

2004 ◽

Vol 26 (11) ◽

pp. 1701-1713 ◽

Author(s):

Franklin C. Lowe

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract Symptoms ◽

Adrenergic Receptor ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Alpha Adrenergic Receptor ◽

Urinary Tract Symptoms ◽

Download Full-text

Influence ofPanax ginsengon Alpha-Adrenergic Receptor of Benign Prostatic Hyperplasia

International Neurourology Journal ◽

10.5213/inj.2014.18.4.179 ◽

2014 ◽

Vol 18 (4) ◽

pp. 179 ◽

Author(s):

Su Kang Kim ◽

Joo-Ho Chung ◽

Byung-Cheol Lee ◽

Sang Won Lee ◽

Kang Hyo Lee ◽

...

Keyword(s):

Benign Prostatic Hyperplasia ◽

Adrenergic Receptor ◽

Prostatic Hyperplasia ◽

Alpha Adrenergic Receptor

Download Full-text

Dose-ranging Study of the Luteinizing Hormone-releasing Hormone Receptor Antagonist Cetrorelix Pamoate in the Treatment of Patients With Symptomatic Benign Prostatic Hyperplasia

Urology ◽

10.1016/j.urology.2009.09.077 ◽

2010 ◽

Vol 76 (4) ◽

pp. 927-933 ◽

Author(s):

Frans Debruyne ◽

Mitko Tzvetkov ◽

Silvio Altarac ◽

Petrisor A. Geavlete

Keyword(s):

Benign Prostatic Hyperplasia ◽

Luteinizing Hormone ◽

Receptor Antagonist ◽

Hormone Receptor ◽

Prostatic Hyperplasia ◽

Symptomatic Benign Prostatic Hyperplasia ◽

Luteinizing Hormone Releasing Hormone ◽

Releasing Hormone ◽

Download Full-text

Long-term outcome of patients with a successful trial without catheter, after treatment with an alpha-adrenergic receptor blocker for acute urinary retention caused by benign prostatic hyperplasia

International Urology and Nephrology ◽

10.1007/s11255-009-9572-7 ◽

2009 ◽

Vol 42 (1) ◽

pp. 7-12 ◽

Author(s):

K. L. Lo ◽

M. C. K. Chan ◽

A. Wong ◽

S. M. Hou ◽

C. F. Ng

Keyword(s):

Benign Prostatic Hyperplasia ◽

Urinary Retention ◽

Adrenergic Receptor ◽

Acute Urinary Retention ◽

Prostatic Hyperplasia ◽

Receptor Blocker ◽

Term Outcome ◽

Long Term Outcome ◽

Alpha Adrenergic Receptor

Download Full-text

1700: Efficacy of Extended-Release Doxazosin and Standard Doxazosin in Patients with Concomitant Benign Prostatic Hyperplasia and Sexual Dysfunction

The Journal of Urology ◽

10.1016/s0022-5347(18)35822-1 ◽

2005 ◽

Vol 173 (4S) ◽

pp. 461-461

Author(s):

Roger S. Kirby ◽

Michael P. O'Leary ◽

Culley C. Carson

Keyword(s):

Benign Prostatic Hyperplasia ◽

Sexual Dysfunction ◽

Extended Release ◽

Prostatic Hyperplasia

Download Full-text